Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $1.6 billion.

  • National Healthcare's Liabilities and Shareholders Equity rose 60.38% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 billion, marking a year-over-year increase of 1219.57%. This contributed to the annual value of $1.5 billion for FY2024, which is 1629.8% up from last year.
  • As of Q3 2025, National Healthcare's Liabilities and Shareholders Equity stood at $1.6 billion, which was up 60.38% from $1.6 billion recorded in Q2 2025.
  • National Healthcare's Liabilities and Shareholders Equity's 5-year high stood at $1.6 billion during Q3 2025, with a 5-year trough of $1.3 billion in Q1 2023.
  • For the 5-year period, National Healthcare's Liabilities and Shareholders Equity averaged around $1.4 billion, with its median value being $1.4 billion (2021).
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first crashed by 911.69% in 2022, then surged by 2190.49% in 2024.
  • Over the past 5 years, National Healthcare's Liabilities and Shareholders Equity (Quarter) stood at $1.4 billion in 2021, then fell by 9.12% to $1.3 billion in 2022, then rose by 2.77% to $1.3 billion in 2023, then rose by 16.3% to $1.5 billion in 2024, then grew by 3.13% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $1.6 billion for Q2 2025, and $1.5 billion during Q1 2025.